Keros Therapeutics, Inc. (KROS)

19.27 -0.26 (-1.33%) USD  |  NASDAQ  |  Jan 15, 16:00
19.27 0.00 (0.00%) After-Hours: 20:00
More

Keros Therapeutics Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Pfizer Inc. Upgrade
Innoviva, Inc. Upgrade
Ocugen, Inc. Upgrade
Bionano Genomics, Inc. Upgrade